Global Review: Health Updates from Rich Nations to Local Policies

This summary covers key updates in the health sector, including vaccine distribution for mpox in Africa, FDA approvals for new medical treatments, changes in Moderna's sales forecasts, Walgreens' legal settlements, and various legislative actions on abortion rights in the U.S. Notable actions by the WHO and China's health body are included.

Following a review of current health updates, rich nations hold millions of vaccine doses as Africa battles an mpox outbreak, prompting questions of international aid. The U.S. FDA has approved Roche's injectable therapy for multiple sclerosis and Eli Lilly's eczema drug, introducing new treatment options for patients. Moderna revised its sales forecast downward, impacting its stock price.

Walgreens is set to pay $106.8 million to settle allegations of fraudulent prescription billing, bringing attention to regulatory compliance issues. Meanwhile, the WHO has approved a new mpox vaccine and established an access scheme for poorer nations. China's health body is advocating for marriage and childbirth at 'appropriate ages' to address declining birth rates.

In the U.S., judicial rulings affect abortion laws: Nebraskans will vote on contradictory abortion-related amendments, and a North Dakota judge overturned the state's near-total abortion ban, reflecting the ongoing legal battles over reproductive rights. Each update underscores significant shifts and decisions within the global health landscape.

(With inputs from agencies.)